Chronic Myelogenous Leukemia in Childhood

[1] Bower H(2016)Life expectancy of patients with chronic myeloid leukemia approaches the life expectancy of the general population J Clin Oncol 34 2851-2857

[2] Björkholm M(2015)Relative survival in patients with chronic-phase chronic myeloid leukaemia in the tyrosine-kinase inhibitor era: analysis of patient data from six prospective clinical trials Lancet Haematol 2 e186-ee93

[3] Dickman PW(2020)Bleeding signs due to acquired von Willebrand syndrome at diagnosis of chronic myeloid leukaemia in children Br J Haematol 188 701-706

[4] Höglund M(2016)Pediatric chronic myeloid leukemia is a unique disease that requires a different approach Blood. 127 392-399

[5] Lambert PC(2015)A review of the European LeukemiaNet recommendations for the management of CML Ann Hematol 94 141-147

[6] Andersson TML(2020)European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia Leukemia. 34 966-984

[7] Sasaki K(2016)The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia Blood. 127 2391-2405

[8] Strom SS(2019)Favourable outcome of de novo advanced phases of childhood chronic myeloid leukaemia Eur J Cancer 115 17-23

[9] O’Brien S(2018)Frequent ASXL1 mutations in children and young adults with chronic myeloid leukemia Leukemia 32 2046-2049

[10] Jabbour E(2013)Cooperating gene mutations in childhood acute myeloid leukemia with special reference on mutations of ASXL1, TET2, IDH1, IDH2, and DNMT3A Blood 121 2988-2995

[1] Bower H(2016)Life expectancy of patients with chronic myeloid leukemia approaches the life expectancy of the general population J Clin Oncol 34 2851-2857

[2] Björkholm M(2015)Relative survival in patients with chronic-phase chronic myeloid leukaemia in the tyrosine-kinase inhibitor era: analysis of patient data from six prospective clinical trials Lancet Haematol 2 e186-ee93

[3] Dickman PW(2020)Bleeding signs due to acquired von Willebrand syndrome at diagnosis of chronic myeloid leukaemia in children Br J Haematol 188 701-706

[4] Höglund M(2016)Pediatric chronic myeloid leukemia is a unique disease that requires a different approach Blood. 127 392-399

[5] Lambert PC(2015)A review of the European LeukemiaNet recommendations for the management of CML Ann Hematol 94 141-147

[6] Andersson TML(2020)European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia Leukemia. 34 966-984

[7] Sasaki K(2016)The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia Blood. 127 2391-2405

[8] Strom SS(2019)Favourable outcome of de novo advanced phases of childhood chronic myeloid leukaemia Eur J Cancer 115 17-23

[9] O’Brien S(2018)Frequent ASXL1 mutations in children and young adults with chronic myeloid leukemia Leukemia 32 2046-2049

[10] Jabbour E(2013)Cooperating gene mutations in childhood acute myeloid leukemia with special reference on mutations of ASXL1, TET2, IDH1, IDH2, and DNMT3A Blood 121 2988-2995